Fundraising FoxCyto-Facto
3 known investors
Find your way into Cyto-Facto
Sign up to see every warm intro you have to Cyto-Facto
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cyto-Facto team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cytofacto appears to be a Japanese startup involved in cell therapy / regenerative medicine, engaging in contract manufacturing of cell-based products (e.g. an agreement regarding manufacturing of "Stemchymal"). The page does not provide a full description of the company's offerings.
Investors · 3
Frequently asked questions
- What does Cyto-Facto do?
- Cytofacto appears to be a Japanese startup involved in cell therapy / regenerative medicine, engaging in contract manufacturing of cell-based products (e.g. an agreement regarding manufacturing of "Stemchymal"). The page does not provide a full description of the company's offerings.
- Who are Cyto-Facto's investors?
- Cyto-Facto's investors include Asahi Kasei Corporate Venture Capital, Kobe University Capital, MPower.